Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes.
Saved in:
| Title: | Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. |
|---|---|
| Authors: | Liberman P; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: pliberm1@jh.edu., Yu SE; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Mendez IJ; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ramos EM; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Berkenstock MK; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Burkholder BM; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Thorne JE; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Department of Epidemiology (J.E.T. and D.A.J.), The Center for Clinical Trials and Evidence Synthesis, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Jabs DA; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Department of Epidemiology (J.E.T. and D.A.J.), The Center for Clinical Trials and Evidence Synthesis, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. |
| Source: | American journal of ophthalmology [Am J Ophthalmol] 2026 Jun 10; Vol. 290, pp. 1-8. Date of Electronic Publication: 2026 Jun 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42263800 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liberman+P%22">Liberman P</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: pliberm1@jh.edu.<br /><searchLink fieldCode="AU" term="%22Yu+SE%22">Yu SE</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Mendez+IJ%22">Mendez IJ</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ramos+EM%22">Ramos EM</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Berkenstock+MK%22">Berkenstock MK</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Burkholder+BM%22">Burkholder BM</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Thorne+JE%22">Thorne JE</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Department of Epidemiology (J.E.T. and D.A.J.), The Center for Clinical Trials and Evidence Synthesis, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Jabs+DA%22">Jabs DA</searchLink>; From the The Department of Ophthalmology (P.L., S.E.Y., I.J.M., E.M.R., M.K.B., B.M.B., J.E.T., D.A.J.), The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Department of Epidemiology (J.E.T. and D.A.J.), The Center for Clinical Trials and Evidence Synthesis, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370500%22">American journal of ophthalmology</searchLink> [Am J Ophthalmol] 2026 Jun 10; Vol. 290, pp. 1-8. <i>Date of Electronic Publication: </i>2026 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1891 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200029394%22">00029394 </searchLink><i>NLM ISO Abbreviation: </i>Am J Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42263800 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ajo.2026.06.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liberman P – PersonEntity: Name: NameFull: Yu SE – PersonEntity: Name: NameFull: Mendez IJ – PersonEntity: Name: NameFull: Ramos EM – PersonEntity: Name: NameFull: Berkenstock MK – PersonEntity: Name: NameFull: Burkholder BM – PersonEntity: Name: NameFull: Thorne JE – PersonEntity: Name: NameFull: Jabs DA IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 06 Text: 2026 Jun 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-1891 Numbering: – Type: volume Value: 290 Titles: – TitleFull: American journal of ophthalmology Type: main |
| ResultId | 1 |